Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/JNJ-26990990> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- JNJ-26990990 abstract "JNJ-26990990 is a broad-spectrum anticonvulsant drug currently under development by Janssen Pharmaceutica as a second-generation followup to the marketed drug topiramate. It was designed to have the same anticonvulsant effects as topirimate, but without the side effects associated with topiramate's carbonic anhydrase inhibition. It also has potential use in the treatment of inflammatory pain, neuropathic pain, and depression.JNJ-26990990 entered phase II clinical trials in October 2007.Metabolites and radioactive isotope-labeled derivatives of JNJ-26990990 have also been prepared to support its development.".
- JNJ-26990990 casNumber "877316-38-6".
- JNJ-26990990 chEBI "580267".
- JNJ-26990990 iupacName "3-[(Sulfamoylamino)methyl]-1-benzothiophene".
- JNJ-26990990 pubchem "11687376".
- JNJ-26990990 thumbnail JNJ-26990990.svg?width=300.
- JNJ-26990990 wikiPageID "32627653".
- JNJ-26990990 wikiPageLength "4630".
- JNJ-26990990 wikiPageOutDegree "15".
- JNJ-26990990 wikiPageRevisionID "673661230".
- JNJ-26990990 wikiPageWikiLink Anticonvulsant.
- JNJ-26990990 wikiPageWikiLink Carbonic_anhydrase.
- JNJ-26990990 wikiPageWikiLink Category:Anticonvulsants.
- JNJ-26990990 wikiPageWikiLink Category:Benzothiophenes.
- JNJ-26990990 wikiPageWikiLink Category:Johnson_&_Johnson.
- JNJ-26990990 wikiPageWikiLink Derivative_(chemistry).
- JNJ-26990990 wikiPageWikiLink Drug_development.
- JNJ-26990990 wikiPageWikiLink Inflammation.
- JNJ-26990990 wikiPageWikiLink JNJ-26489112.
- JNJ-26990990 wikiPageWikiLink Janssen_Pharmaceutica.
- JNJ-26990990 wikiPageWikiLink Major_depressive_disorder.
- JNJ-26990990 wikiPageWikiLink Neuropathic_pain.
- JNJ-26990990 wikiPageWikiLink Pharmaceutical_drug.
- JNJ-26990990 wikiPageWikiLink Phases_of_clinical_research.
- JNJ-26990990 wikiPageWikiLink Topiramate.
- JNJ-26990990 wikiPageWikiLinkText "JNJ-26990990".
- JNJ-26990990 c "9".
- JNJ-26990990 casNumber "877316".
- JNJ-26990990 chebi "580267".
- JNJ-26990990 chembl "466517".
- JNJ-26990990 chemspiderid "9862103".
- JNJ-26990990 h "10".
- JNJ-26990990 iupacName "3".
- JNJ-26990990 molecularWeight "242.3179".
- JNJ-26990990 n "2".
- JNJ-26990990 o "2".
- JNJ-26990990 pubchem "11687376".
- JNJ-26990990 s "2".
- JNJ-26990990 synonyms "N-sulfamide".
- JNJ-26990990 verifiedfields "changed".
- JNJ-26990990 verifiedrevid "444297842".
- JNJ-26990990 watchedfields "changed".
- JNJ-26990990 wikiPageUsesTemplate Template:Cascite.
- JNJ-26990990 wikiPageUsesTemplate Template:Chemspidercite.
- JNJ-26990990 wikiPageUsesTemplate Template:Drugbankcite.
- JNJ-26990990 wikiPageUsesTemplate Template:Drugbox.
- JNJ-26990990 wikiPageUsesTemplate Template:Ebicite.
- JNJ-26990990 wikiPageUsesTemplate Template:Reflist.
- JNJ-26990990 subject Category:Anticonvulsants.
- JNJ-26990990 subject Category:Benzothiophenes.
- JNJ-26990990 subject Category:Johnson_&_Johnson.
- JNJ-26990990 hypernym Drug.
- JNJ-26990990 type ChemicalSubstance.
- JNJ-26990990 type Company.
- JNJ-26990990 type Drug.
- JNJ-26990990 type Anticonvulsant.
- JNJ-26990990 type Chemical.
- JNJ-26990990 type Company.
- JNJ-26990990 type Drug.
- JNJ-26990990 type Heterocycle.
- JNJ-26990990 type ChemicalObject.
- JNJ-26990990 type Thing.
- JNJ-26990990 type Q8386.
- JNJ-26990990 comment "JNJ-26990990 is a broad-spectrum anticonvulsant drug currently under development by Janssen Pharmaceutica as a second-generation followup to the marketed drug topiramate. It was designed to have the same anticonvulsant effects as topirimate, but without the side effects associated with topiramate's carbonic anhydrase inhibition.".
- JNJ-26990990 label "JNJ-26990990".
- JNJ-26990990 sameAs Q15409418.
- JNJ-26990990 sameAs m.0h1hqlm.
- JNJ-26990990 sameAs JNJ-26990990.
- JNJ-26990990 sameAs JNJ-26990990.
- JNJ-26990990 sameAs Q15409418.
- JNJ-26990990 wasDerivedFrom JNJ-26990990?oldid=673661230.
- JNJ-26990990 depiction JNJ-26990990.svg.
- JNJ-26990990 isPrimaryTopicOf JNJ-26990990.